Heparanase inhibition prevents glycocalyx damage and albuminuria in experimental minimal change disease.

Saved in:
Bibliographic Details
Title: Heparanase inhibition prevents glycocalyx damage and albuminuria in experimental minimal change disease.
Authors: Crompton, Michael1 (AUTHOR), Ramnath, Raina D.1 (AUTHOR), Betteridge, Kai1 (AUTHOR), Desideri, Sara1 (AUTHOR), Alonso, Aldara Martin1 (AUTHOR), Jiang, Lulu1 (AUTHOR), Gamez, Monica1 (AUTHOR), Stowell‐Connolly, Holly1 (AUTHOR), Vasylchenko, Viktoriia1 (AUTHOR), Onions, Karen L.1 (AUTHOR), Butler, Matthew J.1 (AUTHOR), Neal, Chris R.1 (AUTHOR), Salmon, Andrew H. J.1 (AUTHOR), Turnbull, Jeremy E.2 (AUTHOR), Kawachi, Hiroshi3 (AUTHOR), Zubkova, Olga V.4 (AUTHOR), Welsh, Gavin I.1 (AUTHOR), Satchell, Simon C.1 (AUTHOR), Foster, Rebecca R.1 (AUTHOR) becky.foster@bristol.ac.uk
Source: Clinical & Translational Medicine. Jun2026, Vol. 16 Issue 6, p1-5. 5p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20011326
DOI:10.1002/ctm2.70706